{
  "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
  "total_chunks": 13,
  "chunks": [
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_000_e5dbfb0a",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 0,
      "text": "# Extendicare## PROCEDURE\n**MANUAL:** Infection Prevention and Control\n**INDEX:** IPC6-P10.01\n**SECTION:** Multi-Drug-Resistant Organisms (MDROs)\n**DESCRIPTION:** Multi-Drug-Resistant Organisms (MDROs)\n**APPROVED BY:** Chief Medical Officer\n**EFFECTIVE DATE:** February 18, 2025\n**REVIEWED DATE:** February 11, 2025\n**MODIFIED DATE:** May 30, 2025----## POLICY\n\n### Multi-Drug-Resistant Organisms (MDROs)## PROCEDURE### Screening\n- Ongoing screening/surveillance cultures will be collected based on local laboratory instructions and health authority guidelines. - The IPAC - MDROs Screening Tool (Multi Drug Resistant Organism) in PointClickCare (PCC) or the MDROs Admission and Readmission Screening Tool are to be used for all resident admissions and re-admissions into the Home.### Management\n- In the event a resident is positive for an MDRO, the registered staff will:\n- Notify the Infection Control Professional/Designate in the Home. - For an MDRO infection or colonization, implement contact precautions (if required) in addition to Routine Practices and as per health authority guidelines. - Post signage and provide residents, families, visitors, and staff information regarding any additional precautions to take and any personal protective equipment (PPE) that should be worn. - Refer to appropriate MDRO procedure. - Dedicate equipment for individual resident use if possible. If equipment cannot be dedicated, it must be cleaned and disinfected with an approved disinfectant before use on another resident.",
      "char_count": 1520,
      "token_estimate": 380,
      "section_title": null,
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_002_1a9e3373",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 2,
      "text": "- Dedicate equipment for individual resident use if possible. If equipment cannot be dedicated, it must be cleaned and disinfected with an approved disinfectant before use on another resident. - If a resident with an MDRO colonization or infection is to be transferred, the MDRO status will be communicated to the receiving site and transport service personnel before the transfer. - Consider placing the infected resident in a room with a resident without an MDRO if the risk of spreading the organism is low when a single room is not possible. Do not, where possible, place a resident with a MDRO infection or colonization in a room with a resident who is palliative or debilitated (requiring considerable amounts of hands-on care) or who has other compromising medical conditions such as open wounds/ulcers, urinary catheters, feeding tubes or invasive devices or compromised hygiene.### Treatment of Infections and Colonizations----**Helping people live better**\nThis document is uncontrolled when printed. Extendicare (Canada) Inc.",
      "char_count": 1036,
      "token_estimate": 259,
      "section_title": "Multi-Drug-Resistant Organisms (MDROs)## PROCEDURE### Screening",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_003_a1fee7c6",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 3,
      "text": "Do not, where possible, place a resident with a MDRO infection or colonization in a room with a resident who is palliative or debilitated (requiring considerable amounts of hands-on care) or who has other compromising medical conditions such as open wounds/ulcers, urinary catheters, feeding tubes or invasive devices or compromised hygiene.### Treatment of Infections and Colonizations----**Helping people live better**\nThis document is uncontrolled when printed. Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025----**Page 1 of 3**# PROCEDURE## SECTION: Multi-Drug-Resistant Organisms (MDROs)",
      "char_count": 823,
      "token_estimate": 205,
      "section_title": "Multi-Drug-Resistant Organisms (MDROs)## PROCEDURE### Screening",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_004_eea765c0",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 4,
      "text": "## DESCRIPTION: Multi-Drug-Resistant Organisms (MDROs)\n\n## INDEX: IPC6-P10.01### Treatment or Decolonization\n- Treatment or decolonization of an MDRO will be determined by the attending physician/nurse practitioner in consultation with the Home and/or based on health authority requirements and guidelines. Decolonization is not supported by best practices. - Specific interventions related to care and treatment of a resident with an MDRO colonization or infection will be documented on the care plan.### Surveillance and Reporting\n- Reporting of MDRO colonization or infection will be conducted as per health authority requirements. - Tracking and surveillance of MDRO infections and colonizations will be conducted in HealthConnex or using the Multi-Drug Resistant Organism (MDRO) Tracking Sheet and as per regional/provincial requirements.",
      "char_count": 843,
      "token_estimate": 210,
      "section_title": "DESCRIPTION: Multi-Drug-Resistant Organisms (MDROs)",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_006_f3a3f5e1",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 6,
      "text": "- Specific interventions related to care and treatment of a resident with an MDRO colonization or infection will be documented on the care plan.### Surveillance and Reporting\n- Reporting of MDRO colonization or infection will be conducted as per health authority requirements. - Tracking and surveillance of MDRO infections and colonizations will be conducted in HealthConnex or using the Multi-Drug Resistant Organism (MDRO) Tracking Sheet and as per regional/provincial requirements. - A consistent system for flagging/deflagging MDRO status on Residents’ health records will be established in the Home based on health authority requirements.### Discontinuation of Precautions\n- Discontinue additional precautions based on clinical symptoms, culture results, and health authority guidelines in consultation with the Infection Control Professional/Designate.#### Retirement Specific:\n- If an MDRO is identified, it will be noted on the plan of care. Appropriate precautions will remain in place until the identified MDRO is cleared, or the resident moves out.#### Alberta and Manitoba Specific:\n- Admission and clearance testing are not recommended.",
      "char_count": 1150,
      "token_estimate": 287,
      "section_title": "INDEX: IPC6-P10.01### Treatment or Decolonization",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_007_b6712b74",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 7,
      "text": "- A consistent system for flagging/deflagging MDRO status on Residents’ health records will be established in the Home based on health authority requirements.### Discontinuation of Precautions\n- Discontinue additional precautions based on clinical symptoms, culture results, and health authority guidelines in consultation with the Infection Control Professional/Designate.#### Retirement Specific:\n- If an MDRO is identified, it will be noted on the plan of care. Appropriate precautions will remain in place until the identified MDRO is cleared, or the resident moves out.#### Alberta and Manitoba Specific:\n- Admission and clearance testing are not recommended. - Assessment of the MDRO positive resident to determine the need for Additional Precautions will be performed by the Home using provincial guidance.## EDUCATION",
      "char_count": 825,
      "token_estimate": 206,
      "section_title": "INDEX: IPC6-P10.01### Treatment or Decolonization",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_008_af0889cc",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 8,
      "text": "1. IPC6-P10-E1 - MDRO Guide\n\n2. IPC6-P10-E2 - Vancomycin Resistant Enterococci (VRE) Fact Sheet",
      "char_count": 95,
      "token_estimate": 23,
      "section_title": "IPC6-P10-E1 - MDRO Guide",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_010_1d8fee1f",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 10,
      "text": "3. IPC6-P10-E3 - Methicillin Resistant Staphylococcus aureus (MRSA) Fact Sheet\n\n4. IPC6-P10-E4 - Extended Spectrum Beta Lactamase (ESBL) Fact Sheet",
      "char_count": 147,
      "token_estimate": 36,
      "section_title": "IPC6-P10-E3 - Methicillin Resistant Staphylococcus aureus (MRSA) Fact Sheet",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_012_6291c52d",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 12,
      "text": "5. IPC6-P10-E5 - Carbapenemase Producing Enterobacterales (CPE) Fact Sheet\n\n6. IPC6-P10-E6 - Candida auris (C. auris) Fact Sheet",
      "char_count": 128,
      "token_estimate": 32,
      "section_title": "IPC6-P10-E5 - Carbapenemase Producing Enterobacterales (CPE) Fact Sheet",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_014_3a14e921",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 14,
      "text": "7. IPC6-P10-E7 - Clostridioides difficile (C. difficile) Fact Sheet## TOOLS\nHelping people live betterThis document is uncontrolled when printed. Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025----**Page 2 of 3**# PROCEDURE## SECTION: Multi-Drug-Resistant Organisms (MDROs)### DESCRIPTION: Multi-Drug-Resistant Organisms (MDROs)### INDEX: IPC6-P10.011. **IPC6-P10-T1** - MDRO Admission and Readmission Screening Tool",
      "char_count": 647,
      "token_estimate": 161,
      "section_title": "IPC6-P10-E7 - Clostridioides difficile (C. difficile) Fact Sheet## TOOLS",
      "chunk_type": "content",
      "start_line": 39,
      "end_line": 40
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_015_1503d7c0",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 15,
      "text": "2. **IPC6-P10-T2** - MDRO Risk Assessment Tool\n\n3. **IPC6-P10-T3** - Multi-Drug-Resistant Organism (MDRO) Screening Algorithm",
      "char_count": 125,
      "token_estimate": 31,
      "section_title": "**IPC6-P10-T2** - MDRO Risk Assessment Tool",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_017_cad3124b",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 17,
      "text": "4. **IPC6-P10-T4** - Multi-Drug-Resistant Organism (MDRO) Tracking Sheet\n\n5. **IPC6-P10-T5** - Testing Program for Multi-Drug Organism (MDRO) Algorithm",
      "char_count": 151,
      "token_estimate": 37,
      "section_title": "**IPC6-P10-T4** - Multi-Drug-Resistant Organism (MDRO) Tracking Sheet",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f_chunk_019_74847eb9",
      "doc_id": "ipc6-p1001-multi-drug-resistantorganismsmdros_8df1af20011f",
      "chunk_index": 19,
      "text": "6. **IPC6-P10-T6** - CPE Risk Assessment----> This document is uncontrolled when printed.\n> Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025\n> Page 3 of 3",
      "char_count": 384,
      "token_estimate": 96,
      "section_title": "**IPC6-P10-T6** - CPE Risk Assessment----> This document is uncontrolled when printed.",
      "chunk_type": "content",
      "start_line": 45,
      "end_line": 47
    }
  ]
}